InvestorsHub Logo
Followers 580
Posts 24791
Boards Moderated 2
Alias Born 06/19/2009

Re: None

Friday, 09/04/2009 3:51:20 PM

Friday, September 04, 2009 3:51:20 PM

Post# of 1318
Trying to find out what may have caused this to fly today and I came across this article about Microfluidic devices which is the industry this company is in. Published yesterday

http://eetimes.eu/uk/219501193

Microfluidic devices market to exceed $3 billion in 2014, says Yole


Anne-Francoise Pele
EE Times Europe
09/03/2009 1:59 PM


PARIS — The market of microfluidic devices is set to exceed $3 billion in 2014, and drug discovery remains the first microfluidics market, according to market trackers Yole Développement (Lyon, France).

In its latest report, entitled 'Emerging Market of Microfluidic Applications', Yole noted that the microfluidics market has experienced regular growth over the last three years. This is based on the sales of the top 150 players worldwide.

Yole observed that today point-of-care (POC) represents 15 percent of the market and has recorded a 37-percent CAGR growth between 2006 and 2009. Following this trend, its share of the microfluidics market for IVD applications is expected to exceed 30 percent by 2014.




Pharmaceutical research, Yole added, is another area where microfluidics will continue to play a significant role. It includes various applications and technologies such as genomics, proteomics and cell research.

Yole noted that cell-based assays represent an opportunity for the microfluidics industry. Cell‐based assays indeed have "a high potential" to replace traditional assays because drug action on single cells and cellular activity can be measured and monitored with very high accuracy, in environments very closed to real living conditions.

Although this specific market is very small today, Yole predicts a tremendous growth in the coming years, anticipated to exceed 30 percent.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.